Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

43.81 -1.54 (-3.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Twist Bioscience Corp

< Previous 1 2 3 4 5 6 7 Next >
Deep Dive Into Twist Bioscience Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Coeur Mining, Medical Properties Trust And RH Are Among Top 7 Mid Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
7 mid-cap stocks with impressive gains last week: CDE, MPW, NGD, RH, AUR, TWST, ALHC. Positive news and financial results drove the surge. 
Via Benzinga
3 Healthcare AI Stocks Positioned for Potential Breakthroughs
The Japanese central bank’s decision creates a prime opportunity. Take advantage of it with these three healthcare AI stocks. 
Via InvestorPlace
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Sotera Health Posts Upbeat Results, Joins Thoughtworks, Sonic Automotive And Other Big Stocks Moving Higher On Monday
Via Benzinga
The 3 Best Med Tech Stocks to Buy Now
Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now. 
Via InvestorPlace
Evaluating Twist Bioscience: Insights From 5 Financial Analysts
Via Benzinga
Key Takeaways From Twist Bioscience Analyst Ratings
Via Benzinga
Expert Outlook: Twist Bioscience Through The Eyes Of 6 Analysts
Via Benzinga
Twist Bioscience Beats Q3 Earnings Forecast, Plans To Achieve 50% Gross Margin By Fiscal Year 2025
Twist Bioscience reported a Q3 adjusted EPS loss of $(0.70), surpassing the $(0.77) consensus. With a net loss of $85.6 million and sales at $81.5 million, Twist Bioscience saw a 27.8% year-over-year... 
Via Benzinga
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
It was another wild week for the market as it had to contend with a lot of news. 
Via Talk Markets
Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
In a recent letter to investors, Cathie Wood, the CEO of ARK Invest, highlighted the potential of the company's flagship fund, ARK Innovation ETF, despite its recent underperformance. 
Via Benzinga
Topics ETFs
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
Via Benzinga
Breaking Down Twist Bioscience: 5 Analysts Share Their Views
Via Benzinga
Analyst Scoreboard: 5 Ratings For Twist Bioscience
Via Benzinga
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts. 
Via Benzinga
Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Via Benzinga
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today. 
Via InvestorPlace
Cathie Wood's Ark Invest Purchases Over $30M of Shopify Shares Amid Q1 Numbers-Driven Plunge; Adds Reddit Shares To Kitty — Offloads Coinbase Stock As Bitcoin Declines
On Wednesday, Cathie Wood’s Ark Invest made some significant trades. 
Via Benzinga
Cathie Wood's Ark Invest Swoops In To Buy The Palantir Dip — Purchases Stock Worth $29M — Offloads Coinbase Shares Worth Over $15M Amid Softening Bitcoin Price
On Tuesday, the Cathie Wood-led Ark Invest made some significant trades. 
Via Benzinga
Genomics firm Twist Bioscience's Momentum To Continue Throughout 2024, Analyst Says
Twist Bioscience reports strong Q2 earnings, with sales up 25% YoY to $75.3M and orders increasing by 45%. Gross margin expands to 41%. Fiscal year guidance was raised, and William Blair sees continued... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
Via Benzinga
TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024
TWST stock results show that Twist Bioscience beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future. 
Via InvestorPlace
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
Via Benzinga
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ: 
Via Benzinga
Is The Stock Market Ready To Plunge? The Warning Signs Are Here...
Find out how to spot the exhaustion of demand and the bearish analogue you could refer to to anticipate the down move. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.